Targeted Combinations May Reduce Cost By Shortening Treatment

Using combinations of targeted oncologics may actually reduce the cost of treatment with the expensive cancer therapies by reducing the duration of treatment, Vanderbilt-Ingram Cancer Center's Carlos Arteaga suggested during ASCO's annual meeting in Atlanta